306 related articles for article (PubMed ID: 32257153)
1. Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence.
Bakkalci D; Jia Y; Winter JR; Lewis JE; Taylor GS; Stagg HR
J Glob Health; 2020 Jun; 10(1):010405. PubMed ID: 32257153
[TBL] [Abstract][Full Text] [Related]
2. Estimating the global burden of Epstein-Barr virus-related cancers.
Wong Y; Meehan MT; Burrows SR; Doolan DL; Miles JJ
J Cancer Res Clin Oncol; 2022 Jan; 148(1):31-46. PubMed ID: 34705104
[TBL] [Abstract][Full Text] [Related]
3. Community detection in Epstein-Barr virus associated carcinomas and role of tyrosine kinase in etiological mechanisms for oncogenesis.
Chatterjee S; Sanjeev BS
Microb Pathog; 2023 Jul; 180():106115. PubMed ID: 37137346
[TBL] [Abstract][Full Text] [Related]
4. Epstein-Barr virus (EBV) and human disease: facts, opinions and problems.
Griffin BE
Mutat Res; 2000 Apr; 462(2-3):395-405. PubMed ID: 11523539
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus and oncogenesis: from latent genes to tumours.
Young LS; Murray PG
Oncogene; 2003 Aug; 22(33):5108-21. PubMed ID: 12910248
[TBL] [Abstract][Full Text] [Related]
6. Pathogenic role of Epstein-Barr virus in human cancer.
Takada K; Shimizu N; Tanabe-Tochikura A; Kuroiwa Y
Intervirology; 1995; 38(3-4):214-20. PubMed ID: 8682619
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus antibodies and the risk of associated malignancies: review of the literature.
Coghill AE; Hildesheim A
Am J Epidemiol; 2014 Oct; 180(7):687-95. PubMed ID: 25167864
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr virus infection and its role in the expanding spectrum of human diseases.
Okano M
Acta Paediatr; 1998 Jan; 87(1):11-8. PubMed ID: 9510440
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus: the first human tumor virus and its role in cancer.
Pagano JS
Proc Assoc Am Physicians; 1999; 111(6):573-80. PubMed ID: 10591086
[TBL] [Abstract][Full Text] [Related]
10. Genome-Wide Analysis of 18 Epstein-Barr Viruses Isolated from Primary Nasopharyngeal Carcinoma Biopsy Specimens.
Tu C; Zeng Z; Qi P; Li X; Yu Z; Guo C; Xiong F; Xiang B; Zhou M; Gong Z; Liao Q; Yu J; He Y; Zhang W; Li X; Li Y; Li G; Xiong W
J Virol; 2017 Sep; 91(17):. PubMed ID: 28637758
[TBL] [Abstract][Full Text] [Related]
11. Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature.
Winter JR; Jackson C; Lewis JE; Taylor GS; Thomas OG; Stagg HR
J Glob Health; 2020 Jun; 10(1):010404. PubMed ID: 32257152
[TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations.
Chu PG; Chang KL; Chen WG; Chen YY; Shibata D; Hayashi K; Bacchi C; Bacchi M; Weiss LM
Am J Pathol; 1999 Sep; 155(3):941-7. PubMed ID: 10487851
[TBL] [Abstract][Full Text] [Related]
13. Associations between environmental factors and serological Epstein-Barr virus antibodies in patients with nasopharyngeal carcinoma in South China.
Zhou T; Yang DW; He YQ; Xue WQ; Liao Y; Zheng MQ; Jia YJ; Yuan LL; Zhang WL; Zeng YX; Jia WH
Cancer Med; 2019 Aug; 8(10):4852-4866. PubMed ID: 31241250
[TBL] [Abstract][Full Text] [Related]
14. HLA Class II alleles and the presence of circulating Epstein-Barr virus DNA in Greek patients with nasopharyngeal carcinoma.
Karanikiotis C; Daniilidis M; Karyotis N; Bakogiannis C; Economopoulos T; Murray S; Papamichael D; Samantas E; Nikolaou A; Skoura L; Tselis N; Zamboglou N; Fountzilas G
Strahlenther Onkol; 2008 Jun; 184(6):325-31. PubMed ID: 18535809
[TBL] [Abstract][Full Text] [Related]
15. Acute or chronic life-threatening diseases associated with Epstein-Barr virus infection.
Okano M; Gross TG
Am J Med Sci; 2012 Jun; 343(6):483-9. PubMed ID: 22104426
[TBL] [Abstract][Full Text] [Related]
16. Association between Antibody Responses to Epstein-Barr Virus Glycoproteins, Neutralization of Infectivity, and the Risk of Nasopharyngeal Carcinoma.
Zhu QY; Kong XW; Sun C; Xie SH; Hildesheim A; Cao SM; Zeng MS
mSphere; 2020 Dec; 5(6):. PubMed ID: 33268566
[TBL] [Abstract][Full Text] [Related]
17. High Levels of Antibody that Neutralize B-cell Infection of Epstein-Barr Virus and that Bind EBV gp350 Are Associated with a Lower Risk of Nasopharyngeal Carcinoma.
Coghill AE; Bu W; Nguyen H; Hsu WL; Yu KJ; Lou PJ; Wang CP; Chen CJ; Hildesheim A; Cohen JI
Clin Cancer Res; 2016 Jul; 22(14):3451-7. PubMed ID: 26920891
[TBL] [Abstract][Full Text] [Related]
18. Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cells.
Sugiura M; Imai S; Tokunaga M; Koizumi S; Uchizawa M; Okamoto K; Osato T
Br J Cancer; 1996 Aug; 74(4):625-31. PubMed ID: 8761381
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.
Kingma DW; Weiss WB; Jaffe ES; Kumar S; Frekko K; Raffeld M
Blood; 1996 Jul; 88(1):242-51. PubMed ID: 8704180
[TBL] [Abstract][Full Text] [Related]
20. Epstein-Barr virus-associated lymphoproliferative disorders.
Grywalska E; Markowicz J; Grabarczyk P; Pasiarski M; Roliński J
Postepy Hig Med Dosw (Online); 2013 May; 67():481-90. PubMed ID: 23752600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
